GNLX - GENELUX Corp
2.8
-0.030 -1.071%
Share volume: 111,330
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.83
-0.03
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-14-2024 | 11-14-2024 | 03-28-2025 | 05-06-2025 | 11-05-2025 | |
| Cash flow financing | 688.000 K | 27.727 M | 0.000 | 91.000 K | 9.567 M | 0.000 | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 14.000 K | 0.000 | |
| Cash flow | -5.357 M | 3.797 M | 0.000 | 2.463 M | 7.641 M | 0.000 | |
| Net income | -7.850 M | -6.576 M | -6.467 M | -8.976 M | -7.492 M | -7.950 M | |
| Depreciation | 84.000 K | 38.000 K | 56.000 K | 57.000 K | 59.000 K | 62.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -1.691 M | -17.106 M | 3.992 M | 6.674 M | 3.509 M | 4.721 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 30.000 K | 228.000 K | 27.000 K | 96.000 K | 30.000 K | 517.000 K | |
| Cash Change | -5.357 M | 3.797 M | -1.756 M | 2.463 M | 7.641 M | -1.854 M |